vs
Side-by-side financial comparison of GUESS INC (GES) and Organon & Co. (OGN). Click either name above to swap in a different company.
Organon & Co. is the larger business by last-quarter revenue ($1.5B vs $791.4M, roughly 1.9× GUESS INC). GUESS INC runs the higher net margin — 3.2% vs -13.6%, a 16.8% gap on every dollar of revenue. On growth, GUESS INC posted the faster year-over-year revenue change (7.2% vs -5.3%). Organon & Co. produced more free cash flow last quarter ($96.0M vs $-56.3M). Over the past eight quarters, Organon & Co.'s revenue compounded faster (-3.6% CAGR vs -5.8%).
Guess?, Inc. is an American clothing company, notable for its black-and-white advertisements. It licenses its brand on other fashion accessories, such as watches, jewelry, perfumes, bags and shoes.
Organon & Co. is an American pharmaceutical company headquartered in Jersey City, New Jersey. Organon specializes in the following core therapeutic fields: reproductive medicine, contraception, psychiatry, hormone replacement therapy (HRT), and anesthesia. Organon produces all its products outside of the United States but receives a third of its revenue from the United States.
GES vs OGN — Head-to-Head
Income Statement — Q3 FY2026 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $791.4M | $1.5B |
| Net Profit | $25.6M | $-205.0M |
| Gross Margin | 42.5% | 49.2% |
| Operating Margin | 2.9% | -9.8% |
| Net Margin | 3.2% | -13.6% |
| Revenue YoY | 7.2% | -5.3% |
| Net Profit YoY | 209.6% | -288.1% |
| EPS (diluted) | $0.48 | $-0.78 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $791.4M | $1.5B | ||
| Q3 25 | $772.9M | $1.6B | ||
| Q2 25 | $647.8M | $1.6B | ||
| Q1 25 | $932.3M | $1.5B | ||
| Q4 24 | $738.5M | $1.6B | ||
| Q3 24 | $732.6M | $1.6B | ||
| Q2 24 | $591.9M | $1.6B | ||
| Q1 24 | $891.0M | $1.6B |
| Q4 25 | $25.6M | $-205.0M | ||
| Q3 25 | $6.2M | $160.0M | ||
| Q2 25 | $-32.9M | $145.0M | ||
| Q1 25 | $81.4M | $87.0M | ||
| Q4 24 | $-23.4M | $109.0M | ||
| Q3 24 | $-10.6M | $359.0M | ||
| Q2 24 | $13.0M | $195.0M | ||
| Q1 24 | $115.3M | $201.0M |
| Q4 25 | 42.5% | 49.2% | ||
| Q3 25 | 42.5% | 53.5% | ||
| Q2 25 | 39.9% | 54.8% | ||
| Q1 25 | 44.1% | 55.6% | ||
| Q4 24 | 43.6% | 56.3% | ||
| Q3 24 | 43.7% | 58.3% | ||
| Q2 24 | 41.9% | 58.4% | ||
| Q1 24 | 45.4% | 59.0% |
| Q4 25 | 2.9% | -9.8% | ||
| Q3 25 | 2.3% | 15.2% | ||
| Q2 25 | -5.1% | 14.4% | ||
| Q1 25 | 11.1% | 6.7% | ||
| Q4 24 | 5.7% | 8.1% | ||
| Q3 24 | 6.5% | 13.1% | ||
| Q2 24 | -3.4% | 14.6% | ||
| Q1 24 | 16.3% | 14.5% |
| Q4 25 | 3.2% | -13.6% | ||
| Q3 25 | 0.8% | 10.0% | ||
| Q2 25 | -5.1% | 9.1% | ||
| Q1 25 | 8.7% | 5.8% | ||
| Q4 24 | -3.2% | 6.8% | ||
| Q3 24 | -1.4% | 22.7% | ||
| Q2 24 | 2.2% | 12.1% | ||
| Q1 24 | 12.9% | 12.4% |
| Q4 25 | $0.48 | $-0.78 | ||
| Q3 25 | $0.12 | $0.61 | ||
| Q2 25 | $-0.65 | $0.56 | ||
| Q1 25 | $1.29 | $0.33 | ||
| Q4 24 | $-0.47 | $0.42 | ||
| Q3 24 | $-0.28 | $1.38 | ||
| Q2 24 | $0.23 | $0.75 | ||
| Q1 24 | $1.90 | $0.78 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $154.2M | $574.0M |
| Total DebtLower is stronger | $299.5M | $8.6B |
| Stockholders' EquityBook value | $508.5M | $752.0M |
| Total Assets | $3.0B | $12.9B |
| Debt / EquityLower = less leverage | 0.59× | 11.49× |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $154.2M | $574.0M | ||
| Q3 25 | $189.6M | $672.0M | ||
| Q2 25 | $151.2M | $599.0M | ||
| Q1 25 | $187.7M | $547.0M | ||
| Q4 24 | $140.9M | $675.0M | ||
| Q3 24 | $218.9M | $763.0M | ||
| Q2 24 | $241.7M | $704.0M | ||
| Q1 24 | $360.3M | $575.0M |
| Q4 25 | $299.5M | $8.6B | ||
| Q3 25 | $258.4M | $8.8B | ||
| Q2 25 | $241.7M | $8.9B | ||
| Q1 25 | $150.7M | $9.0B | ||
| Q4 24 | $238.3M | $8.9B | ||
| Q3 24 | $187.8M | $8.7B | ||
| Q2 24 | $196.9M | $8.7B | ||
| Q1 24 | $28.2M | $8.7B |
| Q4 25 | $508.5M | $752.0M | ||
| Q3 25 | $487.6M | $906.0M | ||
| Q2 25 | $483.6M | $733.0M | ||
| Q1 25 | $505.0M | $542.0M | ||
| Q4 24 | $450.7M | $472.0M | ||
| Q3 24 | $491.2M | $493.0M | ||
| Q2 24 | $565.5M | $144.0M | ||
| Q1 24 | $684.9M | $48.0M |
| Q4 25 | $3.0B | $12.9B | ||
| Q3 25 | $3.0B | $13.6B | ||
| Q2 25 | $2.9B | $13.5B | ||
| Q1 25 | $2.8B | $13.2B | ||
| Q4 24 | $2.8B | $13.1B | ||
| Q3 24 | $2.8B | $12.8B | ||
| Q2 24 | $2.7B | $12.2B | ||
| Q1 24 | $2.6B | $11.9B |
| Q4 25 | 0.59× | 11.49× | ||
| Q3 25 | 0.53× | 9.74× | ||
| Q2 25 | 0.50× | 12.14× | ||
| Q1 25 | 0.30× | 16.52× | ||
| Q4 24 | 0.53× | 18.81× | ||
| Q3 24 | 0.38× | 17.75× | ||
| Q2 24 | 0.35× | 60.11× | ||
| Q1 24 | 0.04× | 181.54× |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $-39.5M | $141.0M |
| Free Cash FlowOCF − Capex | $-56.3M | $96.0M |
| FCF MarginFCF / Revenue | -7.1% | 6.4% |
| Capex IntensityCapex / Revenue | 2.1% | 3.0% |
| Cash ConversionOCF / Net Profit | -1.54× | — |
| TTM Free Cash FlowTrailing 4 quarters | $62.5M | $538.0M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $-39.5M | $141.0M | ||
| Q3 25 | $74.9M | $264.0M | ||
| Q2 25 | $-73.4M | $220.0M | ||
| Q1 25 | $183.2M | $75.0M | ||
| Q4 24 | $-83.3M | $390.0M | ||
| Q3 24 | $44.7M | $141.0M | ||
| Q2 24 | $-22.9M | $332.0M | ||
| Q1 24 | $289.5M | $76.0M |
| Q4 25 | $-56.3M | $96.0M | ||
| Q3 25 | $53.4M | $218.0M | ||
| Q2 25 | $-95.3M | $181.0M | ||
| Q1 25 | $160.7M | $43.0M | ||
| Q4 24 | $-105.4M | $335.0M | ||
| Q3 24 | $24.3M | $99.0M | ||
| Q2 24 | $-44.0M | $300.0M | ||
| Q1 24 | $267.8M | $30.0M |
| Q4 25 | -7.1% | 6.4% | ||
| Q3 25 | 6.9% | 13.6% | ||
| Q2 25 | -14.7% | 11.4% | ||
| Q1 25 | 17.2% | 2.8% | ||
| Q4 24 | -14.3% | 21.0% | ||
| Q3 24 | 3.3% | 6.3% | ||
| Q2 24 | -7.4% | 18.7% | ||
| Q1 24 | 30.1% | 1.8% |
| Q4 25 | 2.1% | 3.0% | ||
| Q3 25 | 2.8% | 2.9% | ||
| Q2 25 | 3.4% | 2.4% | ||
| Q1 25 | 2.4% | 2.1% | ||
| Q4 24 | 3.0% | 3.5% | ||
| Q3 24 | 2.8% | 2.7% | ||
| Q2 24 | 3.6% | 2.0% | ||
| Q1 24 | 2.4% | 2.8% |
| Q4 25 | -1.54× | — | ||
| Q3 25 | 12.00× | 1.65× | ||
| Q2 25 | — | 1.52× | ||
| Q1 25 | 2.25× | 0.86× | ||
| Q4 24 | — | 3.58× | ||
| Q3 24 | — | 0.39× | ||
| Q2 24 | -1.76× | 1.70× | ||
| Q1 24 | 2.51× | 0.38× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
GES
| Products | $760.3M | 96% |
| Royalty | $31.1M | 4% |
OGN
Segment breakdown not available.
